With the advent of immunotherapy, UCSF physicians are incorporating clinical trials into head and neck cancer patient care and changing the treatment paradigm. Dr. Patrick Ha, chief, Head & Neck Surgical Oncology, discusses this novel approach and opportunities with clinical research.
Published
April 30, 2019
Created by
Related Presenters
Chief, Division of Head and Neck Oncologic Surgery
Dr. Patrick Ha is chief of the Division of Head and Neck Oncologic Surgery at UCSF Medical Center as well as the Irwin Mark Jacobs and Joan Klein Jacobs Distinguished Professor in Head and Neck Cancer.
